RE:RE:RE:RE:RE:We are againThe biggest impact Covid had was for QIPT to raise cash and get a wack of free money from the government. Then the other boon of many putting money to work raised all tides, including QIPT. It looks like the after affects of the pandemic - ie supply chain disruptions and limited doctor access has been and continues to be a disruption for many in the DME space hence why the continued consolidation in the space.
Personally, I do think their consolidation efforts will eventually pay dividends and they are continuing to experience organic growth while keeping margins steady.
Short-term (before they report end of August), I think we'll be seeing more sell pressure. We'll probably have a few individuals attempt to push down the price to below 6.40 CAD since they have until August 3rd to keep the price at these level before forced conversion. There also may be some selling after conversion since the debenture holders convert the share to $5.40 CAD and profit the difference.
We'll have to see, but I think we may see a buying opportunity at slightly cheaper prices before the next report. I think management also realise this as well. I'm happy to have sold majority of my shares slightly higher and will sit on the sidelines for the next few weeks.
For Longterm holders - disregard the above. Better days ahead.